SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-091936
Filing Date
2024-04-10
Accepted
2024-04-10 16:26:32
Documents
17
Period of Report
2024-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820872d8k.htm   iXBRL 8-K 48456
2 EX-2.1 d820872dex21.htm EX-2.1 440011
3 EX-10.1 d820872dex101.htm EX-10.1 58526
4 EX-10.2 d820872dex102.htm EX-10.2 65753
5 EX-99.1 d820872dex991.htm EX-99.1 25825
  Complete submission text file 0001193125-24-091936.txt   931590

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alpn-20240410.xsd EX-101.SCH 2890
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alpn-20240410_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alpn-20240410_pre.xml EX-101.PRE 11288
20 EXTRACTED XBRL INSTANCE DOCUMENT d820872d8k_htm.xml XML 3645
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 24836120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)